Viral vectored vaccine development
Professor Sarah Gilbert talks about her work on viral vectored vaccines. Viral vectored vaccines combine a safe virus with a disease protein to protect against specific diseases. These vaccines have the potential to drastically improve public health. Professor Sarah Gilbert has been making and testing vaccines designed to induce T cell responses for ten years, chiefly using antigens from malaria and influenza. Based at the Jenner Institute, several of the vaccines developed in Professor Gilbert's laboratory have progressed into clinical trials.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Epidemics and Vaccines?
This episode is 3 minutes long.
When was this Epidemics and Vaccines episode published?
This episode was published on November 14, 2012.
Can I download this Epidemics and Vaccines episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.